• 1
    Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PFA. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:106674.
  • 2
    NICE. Intrapartum care: management and delivery of care to women in labour. NICE Clinical Guidline. London: NICE, 2007.
  • 3
    WHO. WHO Recommendations for the Prevention of Postpartum Haemorrhage. Geneva: WHO, 2007.
  • 4
    International joint policy statement. FIGO/ICM global initiative to prevent post-partum hemorrhage. J Obstet Gynaecol Can 2004;26:11002, 1108–11.
  • 5
    McCormick ML, Sanghvi HC, Kinzie B, McIntosh N. Preventing postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet 2002;77:26775.
  • 6
    Gulmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2007:CD000494.
  • 7
    Winikoff B, Dabash R, Durocher J, Darwish E, Nguyen TN, Leon W, et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. Lancet 2010;375:2106.
  • 8
    Hofmeyr GJ, Gulmezoglu AM, Novikova N, Linder V, Ferreira S, Piaggio G. Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects. Bull World Health Organ 2009;87:66677.
  • 9
    Dowdle M. Evaluating a new intrauterine pressure catheter. J Reprod Med 1997;42:50613.
  • 10
    Dowdle MA. Comparison of two intrauterine pressure catheters during labor. J Reprod Med 2003;48:5015.
  • 11
    Chong YS, Chua S, El-Refaey H, Choo WL, Chanrachakul B, Tai BC, et al. Postpartum intrauterine pressure studies of the uterotonic effect of oral misoprostol and intramuscular syntometrine. BJOG 2001;108:417.
  • 12
    Chong YS, Chua S, Shen L, Arulkumaran S. Does the route of administration of misoprostol make a difference? The uterotonic effect and side effects of misoprostol given by different routes after vaginal delivery. Eur J Obstet Gynecol Reprod Biol 2004;113:1918.
  • 13
    Chua S, Arulkumaran S, Yang M, Ratnam SS, Steer PJ. The accuracy of catheter-tip pressure transducers for the measurement of intrauterine pressure in labour. Br J Obstet Gynaecol 1992;99:1869.
  • 14
    Chua S, Lee M, Vanaja K, Chong YS, Nordstrom L, Arulkumaran S. The reliability of catheter-tip transducers for the measurement of intrauterine pressure in the third stage of labour. Br J Obstet Gynaecol 1998;105:3526.
  • 15
    Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002;17:3326.
  • 16
    Singh K, Fong YF, Prasad RN, Dong F. Does an acidic medium enhance the efficacy of vaginal misoprostol for pre-abortion cervical priming? Hum Reprod 1999;14:16357.
  • 17
    Weeks A. Oral misoprostol for postpartum haemorrhage. Lancet 2006;368:2123.
  • 18
    Hytten F. Recovery of pelvic organs and tissues. In: HyttenF, editor. The Clinical Physiology of Puerperium. London: Farrand press; 1995. pp. 1129.
  • 19
    Hoj L, Cardoso P, Nielsen BB, Hvidman L, Nielsen J, Aaby P. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial. BMJ 2005;331:723.
  • 20
    Hofmeyr GJ, Nikodem VC, de Jager M, Gelbart BR. A randomised placebo controlled trial of oral misoprostol in the third stage of labour. Br J Obstet Gynaecol 1998;105:9715.
  • 21
    Hofmeyr GJ, Gulmezoglu AM. Misoprostol for the prevention and treatment of postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 2008;22:102541.
  • 22
    Winikoff BBG, Leon W, Durocher J. A case review of high fevers ocurring after adminstering treatment for postpartum hemorrhage in Quito, Ecuador. XVIII FIGO World Congress of Gynecology & Obstetrics. Kuala Lumpur, Malaysia, 2006.
  • 23
    Boulant JA. Role of the preoptic-anterior hypothalamus in thermoregulation and fever. Clin Infect Dis 2000;31 (Suppl 5):S15761.
  • 24
    Kanosue K, Yanase-Fujiwara M, Hosono T. Hypothalamic network for thermoregulatory vasomotor control. Am J Physiol 1994;267:R2838.
  • 25
    Kanosue K, Zhang YH, Yanase-Fujiwara M, Hosono T. Hypothalamic network for thermoregulatory shivering. Am J Physiol 1994;267:R27582.
  • 26
    Gulmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 2001;358:68995.